Natco Pharma Ltd.

Delhi High Court has allowed Natco Pharma to launch Chlorantraniliprole (CTPR) and its formulations, through its non-infringing process. CTPR technical is formulated into broad-spectrum insecticides used across wide range of crops for pest management. The company estimates the current market size of CTPR containing products in India to be over Rs 2000 crore. The Company plans to launch its products very shortly.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.